Hyoscine Butylbromide (buscopan)

# Hyoscine Butylbromide (buscopan) ## Overview Hyoscine butylbromide is an anticholinergic medication that acts as a smooth muscle antispasmodic. It works by blocking muscarinic receptors in the gastrointestinal tract, leading to relaxation of smooth muscle. ## Primary Indications * Symptomatic relief of abdominal pain and cramping associated with irritable bowel syndrome (IBS). * Relief of spasms of the colon, biliary tract, and genitourinary tract. ## Adult Dosing * **Oral:** 20 mg orally up to four times daily. * **Intramuscular/Intravenous:** 20 mg intramuscularly or intravenously, may be repeated every 4 to 8 hours as needed, not exceeding 100 mg in 24 hours. Dosing for severe pain may differ based on local protocols. ## Pediatric Dosing * **Oral:** Generally not recommended for children under 12 years of age. Safety and efficacy have not been established. * **Intramuscular/Intravenous:** Generally not recommended for children under 12 years of age due to lack of established safety and efficacy data. Local protocols may exist for specific situations. ## Dose Adjustments No specific dose adjustments are typically required for hepatic or renal impairment, as the drug has limited systemic absorption and is metabolized peripherally. ## Contraindications * Hypersensitivity to hyoscine butylbromide, atropine, or any component of the formulation. * Myasthenia gravis. * Glaucoma (specifically narrow-angle glaucoma). * Megalocolon. * Paralytic ileus. * Tachyarrhythmias. * Prostatic hypertrophy with urinary retention. * Concurrent use with certain medications (see Key Drug Interactions). ## Adverse Effects Common adverse effects include: * Dry mouth * Blurred vision * Tachycardia * Constipation * Urinary retention * Drowsiness (less common with parenteral routes) * Skin rash, urticaria, itching Rare but serious adverse effects include: * Anaphylactic reactions * Severe allergic reactions ## Key Drug Interactions * **Anticholinergic agents (e.g., atropine, tricyclic antidepressants, antihistamines, some antipsychotics):** Increased risk of anticholinergic side effects. * **Dopamine antagonists (e.g., metoclopramide):** May reduce the efficacy of both drugs. * **Opioid analgesics:** May increase the risk of paralytic ileus. ## Monitoring * Monitor for signs of anticholinergic adverse effects (dry mouth, blurred vision, urinary retention, constipation, tachycardia). * Assess for improvement in abdominal pain and cramping. * Monitor for signs of allergic reactions, especially after parenteral administration. ## Clinical Pearls * Hyoscine butylbromide provides localized antispasmodic action with minimal systemic anticholinergic effects compared to atropine. * It is particularly useful for managing acute colicky pain. * Parenteral administration should be given slowly. * The maximum daily dose for parenteral administration should not be exceeded due to potential for systemic anticholinergic effects. *** *Disclaimer: This information is intended for healthcare professionals. Always consult the most current prescribing information and product monographs for complete details, including indications, contraindications, warnings, precautions, adverse reactions, drug interactions, and dosage adjustments. Local protocols and guidelines should also be considered.*